Study shows how ALS-linked mutations disrupt the protein TDP-43 at the atomic level, preventing it from executing its ...

Biogen’s Qalsody (tofersen) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first ...

Trethera Corporation initiates a clinical trial for TRE-515, exploring its potential in oncology and autoimmune diseases ...

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive muscle weakness. A research ...

A recent study has revealed a critical gap in the use of accessibility features among people living with Amyotrophic Lateral ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its ...

In ALS, the loss of certain proteins turns off a gene called UNC13A that needs to stay active for nerve cell communication, a ...

Neurodegenerative diseases are surging, yet our nation slumbers, unaware of the devastation ahead. This illusion of rarity perpetuates a deadly inaction that extends to all brain diseases. Alzheimer's ...

Researchers from Biotiche Drug Discovery Srl and collaborators have discovered that modulating the activity of a specific ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...

Amyotrophic lateral sclerosis (ALS) - which you may know as the disease that affected Stephen Hawking - is a fatal ...